MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 201 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,074,990 | -20.7% | 1,807,499 | -1.5% | 0.00% | 0.0% |
| Q2 2023 | $22,802,748 | -11.6% | 1,834,493 | -0.3% | 0.00% | 0.0% |
| Q1 2023 | $25,784,691 | -50.2% | 1,840,468 | -49.1% | 0.00% | -50.0% |
| Q4 2022 | $51,750,370 | +15.5% | 3,616,378 | +106.1% | 0.00% | -33.3% |
| Q3 2022 | $44,805,000 | -9.8% | 1,754,976 | +0.3% | 0.00% | 0.0% |
| Q2 2022 | $49,686,000 | -22.2% | 1,748,888 | -3.4% | 0.00% | 0.0% |
| Q1 2022 | $63,850,000 | -5.3% | 1,810,317 | +12.5% | 0.00% | 0.0% |
| Q4 2021 | $67,418,000 | -1.0% | 1,609,033 | +16.0% | 0.00% | -25.0% |
| Q3 2021 | $68,068,000 | +33.7% | 1,386,875 | +13.6% | 0.00% | +33.3% |
| Q2 2021 | $50,927,000 | +120.3% | 1,220,384 | +88.2% | 0.00% | +200.0% |
| Q1 2021 | $23,114,000 | – | 648,529 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $764,690,000 | 24.22% |
| Nekton Capital Ltd. | 1,111,102 | $39,189,000 | 9.66% |
| Pavadi Capital LLC | 133,279 | $4,701,000 | 4.14% |
| Curi Wealth Management, LLC | 420,446 | $14,829,000 | 2.57% |
| Select Equity Group, L.P. | 19,100,056 | $673,659,000 | 2.18% |
| Ownership Capital B.V. | 4,205,521 | $148,329,000 | 1.96% |
| Beck Bode, LLC | 167,969 | $5,924,000 | 1.34% |
| Parkman Healthcare Partners LLC | 77,389 | $2,730,000 | 0.80% |
| STONE RUN CAPITAL, LLC | 55,285 | $1,960,000 | 0.72% |
| Champlain Investment Partners, LLC | 3,582,530 | $126,356,000 | 0.65% |